Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

5.70

+0.02 (0.35%)

At close: Nov 9, 2026, 4:00 PM EST

5.84

+0.14 (2.46%)

Pre-market: Nov 10, 2026, 6:00 AM EST

Orchestra BioMed Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	436	234	152	326	112	206
Market Cap Growth	106.36%	54.11%	-53.41%	191.65%	-45.72%	-21.31%
Enterprise Value	397	171	87	229	193	-
Last Close Price	5.70	4.15	4.00	9.13	9.98	10.08

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13.63	7.00	57.64	118.24	31.67	-263.60
PB Ratio	17.73	3.70	4.61	4.80	2.13	-10.42
P/TBV Ratio	22.55	4.37	4.61	4.80	2.13	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	12.40	5.10	32.97	82.96	54.51	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.40	0.51	0.50	0.03	0.23	-0.29
Net Debt / Equity Ratio	-1.33	-1.17	-1.53	-1.26	-1.37	0.26
Net Debt / EBITDA Ratio	0.68	1.44	0.79	1.68	2.22	0.24
Net Debt / FCF Ratio	0.66	1.50	0.99	1.86	2.41	0.27
Asset Turnover	0.40	0.35	0.03	0.03	0.07	-
Inventory Turnover	0.72	0.79	1.28	0.88	1.23	2.91
Quick Ratio	8.17	6.37	4.13	7.82	4.52	0.90
Current Ratio	8.26	6.45	4.27	7.95	4.56	0.93
Return on Equity (ROE)	-397.30%	-109.41%	-120.84%	-81.47%	-205.22%	-
Return on Assets (ROA)	-45.73%	-33.90%	-46.90%	-33.75%	-37.42%	-52.79%
Return on Capital Employed (ROCE)	-56.70%	-52.80%	-107.20%	-61.30%	-42.40%	-1693.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-17.54%	-22.49%	-40.13%	-15.05%	-30.04%	-11.16%
FCF Yield	-13.56%	-21.10%	-33.44%	-14.16%	-26.70%	-9.56%
Buyback Yield / Dilution	-56.49%	-29.67%	-10.82%	-121.67%	-609.97%	-4.86%

SEC Filings: 10-K · 10-Q